Pint-size CFMOTO 300SR sportsbike on its way to UK
The budget-conscious, stylish CFMOTO 300SR will be launched in Europe and go on sale in the UK in April, it is confirmed.
The CFMOTO 300SR sportsbike is on its way to the UK after the green light was given to the Chinese manufacturer to begin selling the rakish pocket rocket in Europe from April.
The model has been on sale in its native China and the wider Asian region for just over a year and has won plaudits for its eye-catching styling and punchy engine, while it will likely become one of the cheaper sportsbikes on the market available to A2 licence holders.
Pitched as a rival to the Yamaha R3 and KTM RC390, the 300SR will look to capitalise on the success of another Chinese budget pint-size racer the Lexmoto LXR 125, which is consistently ranked as the UK’s best-selling sportsbike
KTM 390 Adventure REVIEW
CFMOTO 300SR is the faired version of the 300NK already available in the UK, but is distinguished by a sharp design, completed by a dynamic front-forward profile and an aggressively tapered front-end arrangement.
Under the skin is a revvy 300cc single-cylinder DOHC motor pumping out 29hp at 8,750rpm and 23.5Nm of torque at 7,250rpm, compared with the R3 at 41hp and the KTM RC390 at 44hp. It is designed for quick responses for urban environments, while CFMOTO have tweaked it to ensure it now meets EuroV compliance.
A full TFT display allows riders to choose between Sport and Rain riding modes from theh dashboard, while full-colour LCD instrument displays add integrated functions such as rpm, speed, gear and phone connectivity,
At the heart of the CFMOTO 300SR’s appeal will also be comprehensive modification kits to give buyers more control over customisation, including tweaks to the clutch, brake levers and guards, footpegs, fuel filler cap, bolt kits and more.
The CFMOTO 300SR will go on sale in April and adds to a growing CFMOTO range that will include the recently-revealed 800MT adventure motorcycle based on the KTM 790 Adventure and the new 700 CL-X Heritage.